✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Agios Pharmaceuticals, Inc.

Common Name
Agios Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
539
Ticker
AGIO
Exchange
Nasdaq
Description
Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medicines for rare diseases through its expertise in cellular metabolism. The company’s core commercial product is PYRU...

Agios Pharmaceuticals's Revenues Data

Explore Agios Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
54,028,000a
36,498,000a
26,823,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Agios Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Agios Pharmaceuticals's 10-K 2025